Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors


    COURSE "SUPPLIER RISK MANAGEMENT" HAS BEEN PRE-APP 2013 - Supplier Risk Management - Webinar By GlobalCompliancePanel

    View: 211

    Website http://bit.ly/U1VJp9 | Want to Edit it Edit Freely

    Category Medical Device, Pharma, Biotech, Clinical, Drug, Food Safety, Heath,FDA

    Deadline: March 12, 2013 | Date: March 12, 2013

    Venue/Country: California, U.S.A

    Updated: 2013-02-22 15:30:44 (GMT+9)

    Call For Papers - CFP

    Overview: One of the hottest topics facing the medical device industry is the evaluation and control of suppliers. Supplier management is typically a partnership between the purchasing department and the quality function. Different goals and objectives can also be a barrier including the quality function reporting into operations, a potential conflict of interest.

    Purchasing controls for medical devices are defined in the Code of Federal Register (CFR) in 21 CFR 820.50. Component suppliers do not have an independent obligation to comply with the Quality System Regulation (QSR) as defined by the Food and Drug Administration (FDA). The onus lies on the finished device manufacturer to specify via a contract or purchase order the level at which suppliers must comply with the QSR. For many smaller suppliers compliance with the QSR is not cost effective, leading the finished medical device manufacturer to use auditing and inspection of components as the only method for controlling suppliers.

    Areas Covered in the Session: Compliance with the FDA's purchasing controls can be defined in five (5) steps:

    Supplier evaluation

    Determination of the level of control to exercise over the supplier

    Recordkeeping or documentation of activities

    Maintaining and/or disseminating purchasing information

    Receiving acceptance activities

    Who Will Benefit:

    Management

    Research and Development

    Regulatory Affairs Personnel

    Quality Assurance/Quality Control Personnel

    Auditors and Inspectors

    Mr. Steven Walfish is the President of Statistical Outsourcing Services, a consulting company that provides statistical analysis and training to FDA regulated industries. Prior to starting Statistical Outsourcing Services, Mr. Walfish was the Senior Manager Biostatistics, Non-clinical at Human Genome Sciences in Rockville MD. Prior to joining HGS, Mr. Walfish was a Senior Associate at PricewaterhouseCoopers specializing in the pharmaceutical industry.

    Price: $225.00

    GlobalCompliancePanel

    Phone: 800-447-9407

    Fax: 302-288-6884

    webinarsatglobalcompliancepanel.com

    http://bit.ly/U1VJp9


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.